Skip to main content
. 2022 Oct 19;16(3):162–169. doi: 10.1177/1753495X221133150

Table 2.

Maternal complications in pregnancies carried to delivery in 35 women with ADTKD-MUC1, 50 women with ADTKD-UMOD and 23 unaffected family members.

Characteristic ADTKD-MUC1 ADTKD-UMOD ADTKD-MUC1 and ADTKD-UMOD Unaffected CKD Stage a
Stage 1 Stage 2 Stage 3 Stage 4
Pregnancies (n) 74 90 164 50 32 (20%) 58 (37%) 54 (34%) 15 (9%)
Twin or greater (n (%)) 2 (3%) 0 2 (1%) 0 0 1 (2%) 1 (2%) 0
Prior hypertension 3 (4%) 9 (10%) 12 (7%) 0 1 (3%) 3 (5%) 6 (11%) 2 (13%)
Diagnosed with new onset high blood pressure during pregnancy (n/pregnancies without prior hypertension (%)) b 6/71 (8%) 17/81 (21%) 23/152 (15%) 6/50 (12%) 4/31 (13%) 6/55 (11%) 11/48 (23%) 2/13 (17%)
High blood pressure during pregnancy (n (%)) 9 (12%) 26 (29%) 35 (21%) 6 (12%) 5 (16%) 9 (16%) 17 (31%) 4 (27%)
Hospitalized for high blood pressure (n (%)) 3 (4%) 9 (10%) 12 (7%) 1 (2%) 1 (3%) 3 (5%) 8 (15%) 0
Diabetes (n (%)) 1 (1%) 1 (1%) 2 (1%) 4 (8%) 1 (3%) 1 (2%) 0 0
Gout (n) 0 0 0 0 0 0 0 0
Proteinuria (n (%)) 4 (5%) 5 (6%) 9 (5%) 1 (2%) 1 (3%) 2 (3%) 6 (11%) 0
Seizures (n (%)) 0 0 0 0 0 0 0 0
Anemia (n (%)) 10 (14%) 9 (10%) 19 (12%) 1 (2%) 6 (19%) 3 (5%) 5 (9%) 5 (33%)
New anemia (n (%)) 8 (11%) 4 (4%) 12 (7%) 1 (2%) 5 (20%) 0 3 (8%) 4 (31%)
Receive erythropoietin or darbopoietin or similar agent to increase hemoglobin (n (%)) 3 (4%) 0 3 (2%) 0 0 0 1 (2%) 2 (13%)*
Swelling in feet or hands (n (%)) 18 (24%) 27 (30%) 45 (27%) 12 (24%) 2 (6%) 20 (34%) ** 16 (30%) * 7 (47%) **
Maintained follow up during pregnancy (n (%)) 47 (64%) 70 (78%) 117 (71%) 36 (72%) 20 (63%) 44 (76%) 37 (69%) 14 (93%)
Other health complications (n (%)) 11 (15%) 9 (10%) 20 (12%) 5 (10%) 4 (13%) 8 (14%) 4 (7%) 4 (27%)
Pregnancies (n) 74 90 164 32 55 42 7
Worsening kidney function (n (%)) 7 (9%) 10 (11%) 17 (10%) NA 0 4 (7%)* 9 (17%)** 4 (27%)**
Dialysis (n (%)) 0 1 (1%) 1 (1%) NA 0 1 (2%) 0 0
a

Five pregnancies were not able to be categorized for CKD stage.

b

The denominator for this row is the number of patients who did not have high blood pressure prior to pregnancy.

*Significantly different than Stage 1 at p < 0.05, **significantly different than Stage 1 at p < 0.01.